17 alpha-hydroxylase deficiency screening
Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
17 alpha-hydroxylase deficiency screening On the Web |
American Roentgen Ray Society Images of 17 alpha-hydroxylase deficiency screening |
Risk calculators and risk factors for 17 alpha-hydroxylase deficiency screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Prenatal screening for congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency by measuring adrenal steroids in the amniotic fluid and monitoring maternal urine steroid metabolite excretion.
Screening
- Measuring adrenal steroids in the amniotic fluid helps in prenatal screening of congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency.[1]
- Monitoring maternal urine steroid metabolite excretion is also used for prenatal screening for congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency
References
- ↑ Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency. Wikipedia (2016). https://en.wikipedia.org/wiki/Congenital_adrenal_hyperplasia_due_to_11%CE%B2-hydroxylase_deficiency Accessed on January 29, 2016